Assessment of Brain Tumor Response to Radiotherapy Using Noninvasive Spectroscopic Magnetic Resonance Imaging...

Area of Science:

• Neuro-oncology
• Radiotherapy response assessment
• Biomarker analysis

Background:

• Brain tumors pose significant challenges in assessing radiotherapy response.
• Metabolic changes are key indicators of tumor activity and treatment effectiveness.

Purpose of the Study:

• To evaluate noninvasive spectroscopic MRI for monitoring brain tumor response to radiotherapy.
• To analyze longitudinal changes in metabolic biomarkers for treatment assessment.

Main Methods:

• Observational longitudinal study including 16 patients with primary brain tumors undergoing radiotherapy.
• Utilized MRI and 3D ^1H-magnetic resonance spectroscopy (MRS) at pretreatment, post-treatment, and follow-up.
• Analyzed key biomarkers (choline, creatine, N-acetylaspartate, lactate) and their ratios using statistical methods including ROC analysis and logistic regression.

Main Results:

• Reduced choline levels indicated decreased tumor proliferation.
• Declining lactate-to-creatine ratios suggested reduced anaerobic metabolism.
• Choline and lactate reductions were identified as predictive indicators of treatment response; higher Karnofsky Performance Status correlated with better outcomes.

Conclusions:

• Noninvasive spectroscopic MRI effectively detects metabolic changes post-radiotherapy, correlating with clinical response.
• Reductions in choline and lactate are key indicators of successful treatment.
• Integration of MRS into routine neuro-oncology imaging is recommended.